Efficacy and Prognosis of Auxiliary Liver Transplantation
NCT ID: NCT07275008
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2025-12-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
NCT01223664
Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure
NCT03084198
Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HE
NCT04317222
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581
Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation
NCT00308100
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
auxiliary liver transplantation
Patients who underwent auxiliary liver transplantation at our center during the study period
No interventions assigned to this group
living donor liver transplantation
Patients who underwent traditional orthotopic living donor liver transplantation at our center during the study period.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with complete medical records and follow-up data.
Exclusion Criteria
2. Patients who underwent other organ transplantation (or multiorgan transplantation).
3. Patients with severe missing postoperative follow-up data or loss to follow-up.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhi-Jun Zhu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhi-Jun Zhu
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BFH20251127004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.